Unum Therapeutics Inc. (UMRX) Prices 5.77M Share IPO at $12/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Unum Therapeutics Announces Pricing of Initial Public Offering
March 28, 2018 9:35 PM EDTCAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX) (Unum Therapeutics), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products designed to harness the power of a patients immune system to cure cancer, today announced the pricing of its initial public offering of 5,770,000 shares of common stock at a public offering price of $12 per share. In addition, Unum Therapeutics has granted the underwriters a 30-day option to purchase up to 865,500 additional shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Unum... More
